4//SEC Filing
O'Loughlin Steve 4
Accession 0001213900-23-100077
CIK 0001388320other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 5:20 PM ET
Size
5.7 KB
Accession
0001213900-23-100077
Insider Transaction Report
Form 4
O'Loughlin Steve
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-12-28+253,123→ 253,123 totalExercise: $5.00Exp: 2033-12-28→ Common Stock (253,123 underlying)
Footnotes (2)
- [F1]This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant.
- [F2]Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested.
Documents
Issuer
Actinium Pharmaceuticals, Inc.
CIK 0001388320
Entity typeother
Related Parties
1- filerCIK 0001615840
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 5:20 PM ET
- Size
- 5.7 KB